Tuesday, August 8, 2023

Emergent BioSolutions to cut jobs at Rockville production facility

Gaithersburg biotech firm Emergent BioSolutions announced this morning that it will lay off 400 employees as part of a restructuring effort to strengthen the company's financial position. Some of the job cuts will be from the firm's Rockville drug production facility, Emergent said in a press release. The company said it will cut back on the services side of its business to focus on its core products, such as medical countermeasures and NARCAN nasal spray. 

“The actions we are taking will further strengthen our core products business and financial foundation,” Emergent interim Chief Executive Officer Haywood Miller said in a statement this morning. “This will better align Emergent’s businesses with a focus on our core products and delivering for the needs of our customers. It will provide us with flexibility to respond to future customer demand while responsibly maintaining manufacturing infrastructure deemed critical to respond to public health threats.”

No comments:

Post a Comment